Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

BUY
$155.75 - $174.48 $778,750 - $872,400
5,000 New
5,000 $778,000
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $448,559 - $503,412
-2,800 Reduced 38.89%
4,400 $777,000
Q3 2022

Nov 01, 2022

BUY
$161.33 - $179.52 $32,266 - $35,904
200 Added 2.86%
7,200 $1.18 Million
Q2 2022

Jul 19, 2022

BUY
$168.19 - $186.01 $790,493 - $874,247
4,700 Added 204.35%
7,000 $1.24 Million
Q1 2022

Apr 29, 2022

BUY
$158.14 - $179.59 $363,721 - $413,057
2,300 New
2,300 $408,000
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $389,825 - $432,525
-2,500 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $403,750 - $448,675
2,500 New
2,500 $404,000
Q2 2021

Aug 02, 2021

SELL
$159.48 - $171.07 $909,035 - $975,099
-5,700 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$153.07 - $170.48 $872,499 - $971,735
5,700 New
5,700 $937,000
Q4 2020

Feb 03, 2021

SELL
$137.11 - $157.38 $918,637 - $1.05 Million
-6,700 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $940,546 - $1.03 Million
6,700 New
6,700 $997,000
Q2 2020

Aug 04, 2020

SELL
$128.81 - $155.51 $888,789 - $1.07 Million
-6,900 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $766,866 - $1.06 Million
6,900 New
6,900 $905,000
Q1 2019

Jun 14, 2019

SELL
$125.72 - $139.79 $930,328 - $1.03 Million
-7,400 Closed
0 $0
Q4 2018

Jun 20, 2019

BUY
$122.84 - $147.84 $909,016 - $1.09 Million
7,400 New
7,400 $955,000
Q3 2018

Jun 20, 2019

SELL
$121.58 - $142.88 $340,424 - $400,064
-2,800 Closed
0 $0
Q2 2018

Jun 20, 2019

SELL
$119.4 - $131.76 $525,360 - $579,744
-4,400 Reduced 61.11%
2,800 $340,000
Q1 2018

Jun 21, 2019

BUY
$125.1 - $148.14 $900,720 - $1.07 Million
7,200 New
7,200 $923,000
Q3 2016

Jul 12, 2019

SELL
N/A
-5,200 Closed
0 $0
Q2 2016

Jul 12, 2019

BUY
N/A
5,200
5,200 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Toews Corp Portfolio

Follow Toews Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

News

Stay updated on Toews Corp with notifications on news.